These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4373410)

  • 1. Inhibition of gross murine leukemia virus replication by rifamycin SV and certain of its derivatives in vitro.
    Shannon WM; Westbrook L; Schabel FM
    Intervirology; 1974; 3(1-2):84-96. PubMed ID: 4373410
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of dexamethasone on replication of ecotropic and xenotropic mouse type C viruses.
    Varnier OE; Levy JA
    Virology; 1979 Jul; 96(2):604-14. PubMed ID: 223319
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.
    Teich N; Lowy DR; Hartley JW; Rowe WP
    Virology; 1973 Jan; 51(1):163-73. PubMed ID: 4346294
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of glucocorticoids on activation of leukemia virus in AKR mouse embryo cells.
    Ihle JN; Lane SE; Kenney FT; Farrelly JG
    Cancer Res; 1975 Feb; 35(2):442-6. PubMed ID: 45895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential susceptibility of spleen focus-forming virus and murine leukemia viruses to ansamycin antibiotics.
    Horoszewicz JS; Leong SS; Carter WA
    Antimicrob Agents Chemother; 1977 Jul; 12(1):4-10. PubMed ID: 18986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-N-Substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives.
    McCarthy JR; Moore JL; Wysong DV
    J Med Chem; 1977 Oct; 20(10):1272-6. PubMed ID: 198544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of 9-beta-D-arabinofuranosyladenine (ara-A) against Gross murine leukemia virus in vitro.
    Shannon WM; Westbrook L; Schabel FM
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):542-5. PubMed ID: 4855983
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of requirement of reverse transcriptase function for the activation of murine leukemia virus by halogenated pyrimidines.
    Pitha PM; Pitha J; Rowe WP
    Virology; 1975 Feb; 63(2):568-72. PubMed ID: 46650
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of endogenous murine leukemia virus from AKR-2B mouse cell line by adriamycin.
    Tomita Y; Kuwata T
    Gan; 1978 Apr; 69(2):287-8. PubMed ID: 210080
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of streptonigrin (NSC-45383) and analogs on oncornavirus replication and DNA polymerase activity.
    Chirigos MA; Pearson JW; Papas TS; Woods WA; Wood HB; Spahn G
    Cancer Chemother Rep; 1973; 57(3):305-9. PubMed ID: 4356395
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line.
    Hackett AJ; Sylvester SS; Joss UR; Calvin M
    Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3653-4. PubMed ID: 4509327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of polyribonucleotide inhibition of ribonucleic acid tumor virus replication: effect of poly(inosinic acid) on the synthesis of proviral deoxyribonucleic acid of murine leukemia virus.
    Arya SK
    Mol Pharmacol; 1977 Jul; 13(4):585-97. PubMed ID: 196171
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers.
    Friedman RM; Chang EH; Ramseur JM; Myers MW
    J Virol; 1975 Sep; 16(3):569-74. PubMed ID: 51100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.
    Shannon WM
    Ann N Y Acad Sci; 1977 Mar; 284():472-507. PubMed ID: 280146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.
    Hays EF; Vredevoe DL
    Cancer Res; 1977 Mar; 37(3):726-30. PubMed ID: 189912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of oncornavirus replication by modified rifamycin antibiotics.
    O'Connor TE
    Ann N Y Acad Sci; 1977 Mar; 284():544-65. PubMed ID: 81643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine.
    Shannon WM; Brockman RW; Westbrook L; Shaddix S; Schabel FM
    J Natl Cancer Inst; 1974 Jan; 52(1):199-205. PubMed ID: 4855758
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of two rifamycin derivatives on the Rous sarcoma virus transformation system.
    Barlati S; Vigier P
    J Gen Virol; 1972 Nov; 17(2):221-5. PubMed ID: 4344314
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenocyte plaque assay for the detection of murine leukemia virus.
    Melief CJ; Datta SK; Louie S; Johnson S; Melief M; Schwartz RS
    Proc Soc Exp Biol Med; 1975 Sep; 149(4):1015-8. PubMed ID: 170622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some implications of the activation of murine leukemia virus by halogenated pyrimidines.
    Rowe WP; Lowy DR; Teich N; Hartley JW
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):1033-5. PubMed ID: 4337234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.